A PHASE 3, MULTI-CENTER, MULTINATIONAL, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO EVALUATE THE EFFICACY AND SAFETY OF MP-376 (LEVOFLOXACIN INHALATION SOLUTION; AEROQUIN) IN STABLE CYSTIC FIBROSIS PATIENTS
|Effective start/end date||2/10/11 → 12/31/12|
- MPEX PHARMACEUTICALS, INC.
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.